Atıf Formatları
Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. Gungordu And E. Aptullahoglu, "Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia.," Investigational new drugs , 2024

Gungordu, S. And Aptullahoglu, E. 2024. Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia.. Investigational new drugs .

Gungordu, S., & Aptullahoglu, E., (2024). Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia.. Investigational new drugs .

Gungordu, Seyda, And ERHAN APTULLAHOĞLU. "Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia.," Investigational new drugs , 2024

Gungordu, Seyda And Aptullahoglu, ERHAN. "Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia.." Investigational new drugs , 2024

Gungordu, S. And Aptullahoglu, E. (2024) . "Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia.." Investigational new drugs .

@article{article, author={Seyda Gungordu And author={ERHAN APTULLAHOĞLU}, title={Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia.}, journal={Investigational new drugs}, year=2024}